Achieve Life Sciences, Inc. — Net Income by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ac401ef3-8270-4053-ace0-668f39e1bc6a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-54.6M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-120690 |
| FY 2024 | $-39.8M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-036831 |
| FY 2023 | $-29.8M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-038049 |
| FY 2022 | $-42.4M | 2022-01-01 – 2022-12-31 | evidence 0001564590-23-003800 |
| FY 2021 | $-33.2M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-009485 |
| FY 2020 | $-14.7M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-012523 |
| FY 2019 | $-16.4M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-010642 |
| FY 2018 | $-12.7M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007838 |
| FY 2017 | $-10.6M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-004159 |
| FY 2016 | $-1.2M | 2016-01-01 – 2016-12-31 | evidence 0001564590-18-004159 |
| FY 2015 | $-828.0k | 2015-01-01 – 2015-12-31 | evidence 0001564590-18-004159 |
| FY 2014 | $-26.2M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-002010 |
| FY 2013 | $-31.8M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-093757 |
| FY 2012 | $-21.1M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-096041 |
| FY 2011 | $-14.7M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-103884 |
| FY 2010 | $-12.6M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-103884 |
| FY 2009 | $-5.5M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-103884 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).